- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Cardiol Therapeutics Inc Class A (CRDL)
Cardiol Therapeutics Inc Class A stock price live, this page displays TSX CRDL stock exchange data. View the CRDL premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Cardiol Therapeutics Inc Class A real time stock price chart below.
What Is the Cardiol Therapeutics Inc Class A Stock Price Today?
The Cardiol Therapeutics Inc Class A stock price today is 1.84.
What Is the Stock Symbol for Cardiol Therapeutics Inc Class A?
The stock symbol for Cardiol Therapeutics Inc Class A is "CRDL."
What Stock Exchange Does Cardiol Therapeutics Inc Class A Trade On?
Cardiol Therapeutics Inc Class A is listed and trades on the Toronto stock exchange.
Is Cardiol Therapeutics Inc Class A a Good Stock to Buy?
Determining whether Cardiol Therapeutics Inc Class A—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CRDL quote. (ISIN: CA14161Y2006)
What Is the Cardiol Therapeutics Inc Class A Stock Price Today?
The Cardiol Therapeutics Inc Class A stock price today is 1.84.
What Is the Stock Symbol for Cardiol Therapeutics Inc Class A?
The stock symbol for Cardiol Therapeutics Inc Class A is "CRDL."
What Stock Exchange Does Cardiol Therapeutics Inc Class A Trade On?
Cardiol Therapeutics Inc Class A is listed and trades on the Toronto stock exchange.
Is Cardiol Therapeutics Inc Class A a Good Stock to Buy?
Determining whether Cardiol Therapeutics Inc Class A—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CRDL quote. (ISIN: CA14161Y2006)
1.84
-0.02(-1.08%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.83
1.87
52 wk Range
1.23
2.33
Earnings results expected in 15 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.831.87
52 wk Range
1.232.33
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
CRDL Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
6.00
Upside
+226.09%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Analyst Ratings
5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 6.00
(+226.09% Upside)
Earnings
Latest Release
Mar 31, 2026
EPS / Forecast
-0.07 / -0.10
Revenue / Forecast
-- / --
Compare CRDL to Peers and Sector
Metrics to compare | CRDL | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCRDLPeersSector | |
|---|---|---|---|---|
P/E Ratio | −6.1x | −2.9x | −0.5x | |
PEG Ratio | −0.25 | −0.01 | 0.00 | |
Price/Book | 11.5x | 0.6x | 2.6x | |
Price / LTM Sales | - | 0.7x | 3.3x | |
Upside (Analyst Target) | 226.1% | 59.0% | 47.7% | |
Fair Value Upside | Unlock | 29.0% | 6.6% | Unlock |
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the developing of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Cardiol Therapeutics (CRDL) Stock Price Today?
The Cardiol Therapeutics stock price today is 1.84 CAD.
What Stock Exchange Does Cardiol Therapeutics Trade On?
Cardiol Therapeutics is listed and trades on the Toronto Stock Exchange.
What Is the Stock Symbol for Cardiol Therapeutics?
The stock symbol for Cardiol Therapeutics is "CRDL."
What Is the Cardiol Therapeutics Market Cap?
As of today, Cardiol Therapeutics market cap is 205.84M CAD.
What Is Cardiol Therapeutics's Earnings Per Share (TTM)?
The Cardiol Therapeutics EPS (TTM) is -0.39.
When Is the Next Cardiol Therapeutics Earnings Date?
Cardiol Therapeutics will release its next earnings report on May 19, 2026.
From a Technical Analysis Perspective, Is CRDL a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Cardiol Therapeutics Stock Split?
Cardiol Therapeutics has split 0 times.
How Many Employees Does Cardiol Therapeutics Have?
Cardiol Therapeutics has 18 employees.
What is the current trading status of Cardiol Therapeutics (CRDL)?
As of May 04, 2026, Cardiol Therapeutics (CRDL) is trading at a price of 1.84 CAD, with a previous close of 1.84 CAD. The stock has fluctuated within a day range of 1.83 CAD to 1.87 CAD, while its 52-week range spans from 1.23 CAD to 2.33 CAD.
What Is Cardiol Therapeutics (CRDL) Price Target According to Analysts?
The average 12-month price target for Cardiol Therapeutics is 6.00 CAD, with a high estimate of 7 CAD and a low estimate of 5 CAD. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +226.09% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.